Page 34 - Ioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ioscience Today - Breaking & Trending Today

Lexaria Bioscience Corp.: Lexaria Discusses Valuation Metrics for Biotech Industry

Third Party Analysis for Biotech and Pharma IndustriesKELOWNA, BC / ACCESSWIRE / August 11, 2022 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator ....

Raphael Rottgen , George Jurcic , Lexaria Bioscience Corp , Drug Administration , Pharma Industries , Third Party Analysis For Biotech , Preclinical Research , Exchange Commission , Company Or Lexaria , Clinical Research , Third Party Analysis , Lexaria Bioscience , Market Drug Safety , Bridge Bio , Bay Bridge Bio , Pharma Tech Outlook , Investigational New Drug ,

Arix Bioscience plc Announces Changes to Board of Directors

DJ Arix Bioscience plc Announces Changes to Board of Directors Arix Bioscience PLC (ARIX) Arix Bioscience plc Announces Changes to Board of Directors 10-Aug-2022 / 07:01 GMT/BST Dissemination of ....

United Kingdom , City Of , Ibrahim Khalil , Andrew Smith , Sarah Macleod , Arix Bioscience , Benny Soffer , Nick Johnson , Smithkline Beecham , Michael Bunbury , Debra Barker , Yale University , Santhera Pharmaceuticals , Emory University , Queen College , Institute Of Management Accountants , Powerscourt Group , Durham University Business School , King College , News Service , Company Audit Committee , Company Remuneration Committee , Liverpool John Moores University , Sucampo Pharmaceuticals Inc , Announces Changes , Regulatory Announcement ,

Lexaria Bioscience Corp.: Lexaria Announces Positive Feedback from Pre-IND Meeting with FDA on DehydraTECH-CBD for Hypertension

Significant Milestone Achieved in Commercial Product Development ProgramAbbreviated 505(b)(2) Strategy Confirmed as an Appropriate NDA PathwayKELOWNA, BC / ACCESSWIRE / August 10, 2022 / Lexaria Bioscience ....

United States , John Docherty , George Jurcic , Exchange Commission , Company Or Lexaria , Lexaria Bioscience Corp , Drug Administration , Significant Milestone Achieved , Commercial Product Development , Strategy Confirmed , Lexaria Bioscience , Investigational New Drug ,

Arix Bioscience PLC: Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini Therapeutics

DJ Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini Therapeutics Arix Bioscience PLC (ARIX) Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini ....

City Of , United Kingdom , Nick Johnson , Ibrahim Khalil , Robert Lyne , Sarah Macleod , Arix Bioscience , Disc Medicine Inc , Powerscourt Group , Atlas Venture , Gemini Therapeutics Inc , News Service , Novo Holdings , Gemini Therapeutics , Regulatory Announcement , Disc Medicine , Nasdaq Global Market , Access Biotechnology , Rock Springs Capital , Janus Henderson , Erythropoietic Protoporphyria , X Linked Protoporphyria , Heme Synthesis Modulator , Diamond Blackfan Anemia , Hepcidin Suppression , Hepcidin Induction ,

Arix Bioscience PLC: Artios initiates Phase 2 study of Pol? Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer

DJ Artios initiates Phase 2 study of Pol? Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer Arix Bioscience PLC (ARIX) Artios initiates Phase 2 study ....

New York , United States , United Kingdom , City Of , Ibrahim Khalil , Timothy Yap , Sarah Macleod , Arix Bioscience , Artios Pharma , Niall Martin , Nature Communications , Sarah Cannon Research Institute At Tennessee Oncology , Artios Press , Artios Pharma Limited , Merck Kga , Crick Institute , Netherlands Cancer Institute , News Service , Babraham Research Campus In Cambridge , Cancer Research Technology , Cancer Research Horizons , University Of Texas Md Anderson Cancer Center , Powerscourt Group , Institute For Applied Cancer Science , Institute Of Cancer Research , Cancer Research United Kingdom ,